A carregar...
(Not Giving Up) The Marathon Race of MET Targeting Therapy - Are We There Yet?
Among various MET aberrations, MET amplification and METex14 have emerged as valid predictive biomarkers for MET inhibition. Despite challenges that have limited the development of MET inhibitors, we can learn from the latest efforts in biomarker-based therapy to better identify the patients who wil...
Na minha lista:
| Publicado no: | Clin Cancer Res |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6504968/ https://ncbi.nlm.nih.gov/pubmed/30770350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-3739 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|